These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 38628650)

  • 21. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of laser and light therapy in melasma.
    Trivedi MK; Yang FC; Cho BK
    Int J Womens Dermatol; 2017 Mar; 3(1):11-20. PubMed ID: 28492049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melasma: an Up-to-Date Comprehensive Review.
    Ogbechie-Godec OA; Elbuluk N
    Dermatol Ther (Heidelb); 2017 Sep; 7(3):305-318. PubMed ID: 28726212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective Analysis of Endemic Melasma Patients.
    Demirkan S; Gündüz Ö; Sayan CD
    Dermatol Reports; 2017 Mar; 9(1):7027. PubMed ID: 28652905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
    Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
    Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical treatment of melasma.
    Bandyopadhyay D
    Indian J Dermatol; 2009; 54(4):303-9. PubMed ID: 20101327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.
    Cantelli M; Ferrillo M; Granger C; Fabbrocini G
    J Cosmet Dermatol; 2022 Apr; 21(4):1523-1532. PubMed ID: 34087055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melasma.
    Wu IB; Lambert C; Lotti TM; Hercogová J; Sintim-Damoa A; Schwartz RA
    G Ital Dermatol Venereol; 2012 Aug; 147(4):413-8. PubMed ID: 23007216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradermal Platelet-Rich Plasma for the Treatment of Melasma: A Clinical and Dermoscopic Evaluation in Dark Skin.
    Rout A; Mani S; Bala N
    J Cutan Aesthet Surg; 2023; 16(4):300-305. PubMed ID: 38314355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical and Systemic Therapies in Melasma: A Systematic Review.
    Sarkar R; Handog EB; Das A; Bansal A; Macarayo MJ; Keshavmurthy V; Narayan V; Jagadeesan S; Pipo E; Ibaviosa GM; Podder I; Bansal S
    Indian Dermatol Online J; 2023; 14(6):769-781. PubMed ID: 38099013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease characteristics, determinants, and perception of use of sunscreen and sun-protective behaviors among patients of color with melasma: A cross-sectional study.
    Seetan K; Shatanawi M; Ali A; Khamees A; Alsheikh A; Alawneh A; Al-Shami M; Al-Shar'e H
    Photodermatol Photoimmunol Photomed; 2022 Sep; 38(5):495-500. PubMed ID: 35108414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review.
    Lee YS; Lee YJ; Lee JM; Han TY; Lee JH; Choi JE
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
    Lueangarun S; Namboonlue C; Tempark T
    J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of microneedling with topical vitamin C in the treatment of melasma.
    Ismail ESA; Patsatsi A; Abd El-Maged WM; Nada EEAE
    J Cosmet Dermatol; 2019 Oct; 18(5):1342-1347. PubMed ID: 30770637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials.
    Austin E; Nguyen JK; Jagdeo J
    J Drugs Dermatol; 2019 Nov; 18(11):. PubMed ID: 31741361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
    Sofen B; Prado G; Emer J
    Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pigmentation control in pregnancy-induced melasma: Clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum.
    Makino ET; Jiang LI; Stephens TJ; Mikati M; Mehta RC
    J Cosmet Dermatol; 2022 Nov; 21(11):5739-5746. PubMed ID: 35708506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages.
    Ghasemiyeh P; Mohammadi-Samani S
    Drug Des Devel Ther; 2020; 14():3271-3289. PubMed ID: 32848366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tam formula: A pilot study for a new treatment for melasma.
    Srivastava R; John AM; Tam A; Firoz BF
    J Cosmet Dermatol; 2021 Jul; 20(7):2168-2171. PubMed ID: 33206439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.